Correlation Between Centessa Pharmaceuticals and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Tarsus Pharmaceuticals.
Diversification Opportunities for Centessa Pharmaceuticals and Tarsus Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Centessa and Tarsus is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Centessa Pharmaceuticals is expected to generate 1.01 times less return on investment than Tarsus Pharmaceuticals. But when comparing it to its historical volatility, Centessa Pharmaceuticals PLC is 1.02 times less risky than Tarsus Pharmaceuticals. It trades about 0.26 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest 3,900 in Tarsus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 758.00 from holding Tarsus Pharmaceuticals or generate 19.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 95.65% |
Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Tarsus Pharmaceuticals
Performance |
Timeline |
Centessa Pharmaceuticals |
Tarsus Pharmaceuticals |
Centessa Pharmaceuticals and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Centessa Pharmaceuticals and Tarsus Pharmaceuticals
The main advantage of trading using opposite Centessa Pharmaceuticals and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.The idea behind Centessa Pharmaceuticals PLC and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |